Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA User Fees: Complex Generics, Transparency, Communications Are Early Negotiation Targets
Jul 11 2025
•
By
Sue Sutter
The generic drug industry shared its wish list for GDUFA IV.
(Shutterstock)
More from User Fees
More from United States